GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Strides Pharma Science STAR.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

1,002.20

+0.26%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹45.65bn

FY2016FY2025

Net income

₹35.93bn

FY2016FY2025

Free cash flow

₹4.42bn

FY2016FY2025

Shareholders' equity

₹25.52bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹45.65bn₹38.90bn₹36.88bn₹30.70bn₹33.16bn₹27.52bn₹21.78bn₹28.45bn₹27.55bn₹28.62bn
Gross profit₹23.73bn₹19.31bn₹18.57bn₹13.67bn₹17.97bn₹14.70bn₹9.75bn₹13.50bn₹13.54bn₹12.19bn
Operating income₹6.13bn₹3.71bn₹1.45bn−₹2.35bn₹4.33bn₹3.74bn₹1.48bn₹2.59bn₹4.07bn₹2.90bn
Net income₹35.93bn−₹706.1m−₹2.03bn−₹4.60bn₹2.68bn₹364.0m₹3.25bn₹6.64bn₹4.00bn₹1.08bn
Diluted earnings per share390.50-7.75-22.49-51.1329.824.0436.0673.8344.4113.07

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹60.49bn₹58.40bn₹66.38bn₹69.76bn₹70.15bn₹61.52bn₹79.80bn₹67.08bn₹82.74bn₹74.56bn
Cash and short-term investments₹1.99bn₹2.90bn₹3.61bn₹1.84bn₹2.75bn₹3.47bn₹7.92bn₹6.07bn₹17.36bn₹15.12bn
Total liabilities₹34.97bn₹37.14bn₹44.26bn₹46.17bn₹42.38bn₹36.24bn₹53.31bn₹42.45bn₹55.20bn₹47.98bn
Debt₹18.80bn₹25.17bn₹30.30bn₹30.25bn₹23.48bn₹22.35bn₹32.22bn₹25.20bn₹30.32bn₹35.42bn
Shareholders' equity₹25.52bn₹21.26bn₹22.12bn₹23.59bn₹27.77bn₹25.27bn₹26.49bn₹24.64bn₹27.54bn₹26.58bn
Shares outstanding92m91m90m90m90m90m90m90m90m83m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₹6.84bn₹7.01bn₹440.7m−₹2.58bn₹4.81bn₹2.05bn₹600.6m₹1.72bn−₹2.51bn₹895.7m
Capital spending−₹2.42bn−₹1.18bn−₹949.4m−₹1.43bn−₹2.97bn−₹1.50bn−₹3.29bn−₹4.03bn−₹6.82bn−₹3.69bn
Free cash flow₹4.42bn₹5.83bn−₹508.7m−₹4.01bn₹1.84bn₹547.9m−₹2.69bn−₹2.31bn−₹9.33bn−₹2.80bn
Dividends paid−₹229.9m−₹135.2m—−₹224.3m−₹179.2m−₹1.54bn−₹179.5m−₹442.9m−₹432.3m−₹246.1m

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Revenue₹12.21bn₹11.20bn₹11.90bn₹11.54bn₹12.01bn₹10.88bn₹10.84bn₹10.38bn
Gross profit₹7.06bn₹6.75bn₹6.91bn₹6.74bn₹7.03bn₹6.67bn₹6.68bn₹6.16bn
Operating income₹1.82bn₹1.69bn₹1.69bn₹1.62bn₹1.85bn₹1.68bn₹1.70bn₹1.43bn
Net income₹1.28bn₹996.1m₹821.9m₹879.5m₹932.3m₹702.0m₹181.8m₹496.7m
Diluted earnings per share13.8410.818.929.5610.127.621.975.43
Total assets₹65.21bn—₹60.49bn—₹59.90bn—₹58.40bn—
Cash and short-term investments₹4.30bn—₹3.81bn—₹3.35bn—₹4.16bn—
Debt₹5.53bn—₹6.23bn—₹6.39bn—₹7.43bn—
Shareholders' equity₹27.56bn—₹25.52bn—₹22.71bn—₹21.26bn—

Financial ratios

Data as of 12 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin36.4%26.4%22.2%21.9%13.4%29.2%—
Operating margin14.9%11.6%7.9%3.4%-15.6%9.6%—
Net margin11.4%9.1%-3.1%-6.0%-15.0%7.8%—
Return on equity17.9%15.9%-5.7%-10.0%-19.5%9.2%—
Return on assets8.0%6.7%-2.1%-3.3%-6.6%3.6%—
Free cash flow yield8.8%8.5%7.5%1.3%-1.1%7.3%—
Revenue growth8.6%16.9%4.4%19.9%-6.8%22.3%—
Earnings growth37.2%-437.2%-45.7%-51.9%-280.8%954.0%—
Current ratio1.25x1.20x1.03x1.08x0.99x1.03x—
Debt to equity0.55x0.72x1.15x1.28x1.20x0.77x—
Equity ratio44.9%42.2%36.4%33.3%33.8%39.6%—
Interest coverage4.05x2.08x1.08x0.47x-2.69x2.10x—
R&D as a share of sales—1.5%1.6%1.7%2.9%3.2%3.9%
Buybacks as a share of market value0.0%-0.1%-0.5%-1.5%-0.6%-0.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.1%10.7%14.3%
Operating income—10.4%12.7%
Net income—150.5%15.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.9%49.5%50.7%49.2%
Operating margin11.6%5.9%8.0%9.0%
Net margin41.7%18.8%14.9%16.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings2.3-85.3-13.3-3.16.999.54.62.98.236.0
Price to sales1.81.60.70.50.61.30.70.71.21.4

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 31 Jul 2026.

FY2026FY2025FY2024FY2022FY2021FY2020FY2019FY2018
Paid in the year4.002.501.502.502.0015.002.004.50
  • 1-to-1 reverse split · 24 Dec 2001

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.